Reuters

(Reuters)

CVS in $20M Settlement with SEC Over Accounting

Features Reuters

CVS Caremark Corp agreed to pay $20 million to settle U.S. Securities and Exchange Commission charges that it misled investors about significant financial setbacks and used improper accounting to artificially boost its results.

Continue Reading Below

The Woonsocket, Rhode Island-based company did not admit or deny wrongdoing in agreeing to settle.

CVS operates the second-largest U.S. drugstore chain. (Reporting by Jonathan Stempel in New York)

Continue Reading Below